- Plecanatide
-
- $28.00 / 1box
-
2024-04-12
- CAS:467426-54-6
- Min. Order: 1box
- Purity: 99%
- Supply Ability: 20000
- Plecanatide
-
- $30.00/ kg
-
2024-03-31
- CAS:467426-54-6
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 2000000
- Plecanatide
-
- $10.00 / 1kg
-
2024-03-08
- CAS:467426-54-6
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000kg
|
| | Plecanatide Basic information |
| Product Name: | Plecanatide | | Synonyms: | Plecanatide;ASN-ASP-GLU-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU(DISULFIDE BOND CYS1&CYS3,CYS2&CYS4);Plecanatide Impurtiy;L-Leucine, L-asparaginyl-L-α-aspartyl-L-α-glutamyl-L-cysteinyl-L-α-glutamyl-L-leucyl-L-cysteinyl-L-valyl-L-asparaginyl-L-valyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (4→12),(7→15)-bis(disulfide);Plecanatide impurity;Plecanatide USP/EP/BP;Prikanatide;ATCH(1-39) | | CAS: | 467426-54-6 | | MF: | C65H104N18O26S4 | | MW: | 1681.89 | | EINECS: | | | Product Categories: | | | Mol File: | 467426-54-6.mol |  |
| | Plecanatide Chemical Properties |
| Boiling point | 2120.0±65.0 °C(Predicted) | | density | 1.47±0.1 g/cm3(Predicted) | | pka | 3.61±0.21(Predicted) | | InChIKey | NSPHQWLKCGGCQR-DLJDZFDSSA-N |
| | Plecanatide Usage And Synthesis |
| Uses | Plecanatide is used in the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation. It works as a laxative by drawing water in to the gastrointestinal tract thereby softening stool and encouraging its natural passage. | | Enzyme inhibitor | This uroguanylin analogue (FW = 1681.90 g/mol; CAS 467426-54-6), also known by the codename SP-304, binds to and activates guanylate cyclase-C (GC-C) receptors (EC50 ≈ 0.3 μM) expressed on the epithelial cells lining turn sequentially activates protein kinase G-II and the chloride channel known as the Cystic Fibrosis Transmembrane-conductance Regulator (CFTR) to regulate ion and fluid transport, to promote epithelial cell homeostasis, and to maintain barrier function in the GI mucosa. Plecanatide is a hexadecapeptide that is structurally identical to uroguanylin, except for an glutamate substitution at position-3. Oral treatment with plecanatide at a dose range between 0.05-2.5 mg/kg per day is as effective as once-daily treatment with 5-amino salicylic acid (100 mg/kg) or sulfasalazine (80 mg/kg). Amelioration of colitis by the treatment with plecanatide or dolcanatide was not dose-dependent, most likely due to saturation of available GC-C receptors. |
| | Plecanatide Preparation Products And Raw materials |
|